All patients with type 1 diabetes in England will now be eligible for continuous glucose monitors, the NHS has announced.

NHS England said it had secured a deal with the manufacturer Dexcom to make continuous glucose monitors available on prescription at a similar price to flash monitor counterparts.

The devices, called Dexcom ONE Real Time-Continuous Glucose Monitoring, can be worn on the arm for up to 10 days. They use a sensor no larger than a bottle cap to measure glucose levels from under the skin, sending information to a mobile app for patients to track without having …

If you have a subscription to The BMJ, log in:

Subscribe and get access to all BMJ articles, and much more.

Access this article for 1 day for: £30 / $37 / €33 (excludes VAT)

You can download a PDF version for your personal record.

Register for alerts If you have registered for alerts, you should use your registered email address as your username

If you are unable to import citations, please contact technical support for your product directly (links go to external sites):

Thank you for your interest in spreading the word about The BMJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.